From: Correlation of miR-31 and miR-373 expression with KRAS mutations and its impact on prognosis in colorectal cancer
Mutations
Results
N (%)
KRAS codon 12 mutation
Positive
31 (20.6%)
Negative
119 (79.4%)
KRAS codon 13 mutation
22 (14.6%)
128 (85.4%)